Loading...

Burning Rock Biotech Limited

BNRNASDAQ
Healthcare
Medical - Diagnostics & Research
$9.13
$-0.21(-2.29%)

Burning Rock Biotech Limited (BNR) Stock Overview

Explore Burning Rock Biotech Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 63.9/100

Key Financials

Market Cap9M
P/E Ratio-0.29
EPS (TTM)$-3.22
ROE-0.39%
Fundamental Analysis

AI Price Forecasts

1 Week$3.04
1 Month$1.31
3 Months$0.00
1 Year Target$1.71

BNR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Burning Rock Biotech Limited (BNR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 59.98, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.71.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.29 and a market capitalization of 9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-9.68%
5-Day Change
-18.42%
1-Month Change
-38.07%
3-Month Change
-56.77%
6-Month Change
-7.76%
Year-to-Date (YTD) Change
-58.94%
1-Year Change
-59.48%
3-Year Change
-96.45%
5-Year Change
-98.77%
All-Time (Max) Change
-98.77%

Contact Information

86 20 3403 7871
No. 5, Xingdao Ring Road North, Guangzhou, 510005

Company Facts

674 Employees
IPO DateJun 12, 2020
CountryCN
Actively Trading

Frequently Asked Questions

;